Insomnia, Fatal Familial: Clinical Trials

4 trials for Insomnia, Fatal Familial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Unknown 1
Phase 11Not yet recruiting 1

Follow Insomnia, Fatal Familial: new trials by email Literature Review of Insomnia, Fatal Familial trials Research Report on Insomnia, Fatal Familial

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)
ALN-6457 - Prion Disease
Phase 1 / Phase 2Not yet recruitingRegeneron Pharmaceuticals602026-10-232026-09-22
Knee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment Methods
autologous adipose tissue transfer, PRP injections - Osteo Arthritis Knee, Knee Osteoarthritis
Phase 2UnknownRehasport Clinic602018-07-302020-03-25
Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk
Doxycycline Hcl, Placebo - Familial Fatal Insomnia
Phase 2CompletedMario Negri Institute for Pharmacological Research292011-04-282024-12-05
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Quinacrine, Placebo - Creutzfeldt-Jakob Disease
Phase 2CompletedUniversity of California, San Francisco692005-04-012014-06-09

Narrower conditions

Creutzfeldt-Jakob Syndrome (2)  ·  Dementia (2)  ·  Prion Diseases (2)  ·  Arthritis (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Gerstmann-Straussler-Scheinker Disease (1)  ·  Joint Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Osteoarthritis, Knee (1)  ·  Proteostasis Deficiencies (1)

Broader conditions

Dyssomnias (4)  ·  Infections (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Sleep Initiation and Maintenance Disorders (4)  ·  Sleep Wake Disorders (4)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Infections (3)  ·  Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Brain Diseases (2)  ·  Mental Disorders (2)  ·  Neurocognitive Disorders (2)  ·  Prion Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Quinacrine (1)

Sponsors

Mario Negri Institute for Pharmacological Research (1)  ·  Regeneron Pharmaceuticals (1)  ·  Rehasport Clinic (1)  ·  University of California, San Francisco (1)

Countries

Poland (1)  ·  United States (1)

Top investigators

Bruce L. Miller, MD (1)  ·  Michael Geschwind, MD, PhD (1)  ·  Pawel Bakowski, MD PhD (1)  ·  Tomasz Piontek, MD PhD (1)

Results publications

PMID 24122181, PMID 32434498

NIH funding

P01AG021601 (1)